IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,533 | +6.4% | 58 | 0.0% | 0.00% | – |
Q2 2023 | $2,380 | +18.2% | 58 | 0.0% | 0.00% | – |
Q1 2023 | $2,014 | +4.6% | 58 | +13.7% | 0.00% | – |
Q4 2022 | $1,926 | -3.7% | 51 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | -99.7% | 51 | -99.8% | 0.00% | -100.0% |
Q2 2022 | $756,000 | +0.1% | 20,431 | +0.4% | 0.06% | +3.4% |
Q1 2022 | $755,000 | +289.2% | 20,341 | +251.7% | 0.06% | +210.5% |
Q3 2021 | $194,000 | -8.5% | 5,784 | +8.9% | 0.02% | -13.6% |
Q2 2021 | $212,000 | +2.4% | 5,313 | +15.2% | 0.02% | -8.3% |
Q1 2021 | $207,000 | +10250.0% | 4,611 | +11146.3% | 0.02% | – |
Q1 2020 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -89.5% | 41 | -86.0% | 0.00% | -100.0% |
Q2 2019 | $19,000 | -20.8% | 293 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $24,000 | +50.0% | 293 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $16,000 | +33.3% | 293 | +26.8% | 0.00% | +33.3% |
Q3 2018 | $12,000 | +33.3% | 231 | +13.2% | 0.00% | +50.0% |
Q2 2018 | $9,000 | +350.0% | 204 | +397.6% | 0.00% | +100.0% |
Q1 2018 | $2,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |